Rose Therapeutics, Inc.

Biotechnology company · Norristown, Pennsylvania, United States

Rose Therapeutics, Inc. is a biotechnology company headquartered in Norristown, Pennsylvania, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $650,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Rose Therapeutics at a glance

Typebiotechnology company
HeadquartersNorristown, Pennsylvania, United States
Earliest incorporation on record2022
SEC CIK1944189

What does Rose Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $650,000 sold (2022).

Frequently asked questions about Rose Therapeutics

Where is Rose Therapeutics headquartered?

Rose Therapeutics, Inc. is headquartered in Norristown, Pennsylvania, United States.

What does Rose Therapeutics do?

Rose Therapeutics, Inc. is a biotechnology company.

When was Rose Therapeutics founded?

The earliest incorporation on record for Rose Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences

Rose Therapeutics: Headquarters, Locations & Company Profile (2026) | BioBridgeX